Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117280) titled 'A Single-Center, Randomized Controlled Clinical Study of Injectable Hyaluronidase Combined with Celecoxib Capsules for the Treatment of Osteoarthritis' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Knee osteoarthritis
Intervention:
Control Group:Oral Celecoxib Capsules (Celebrex), 200 mg, once daily
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-26
Target Sample Size: Control Group:25;Experimental group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr...